Publishing Knowledge. Connecting Professionals. Advancing Pathology.
24
Platforms Reviewed
8
FDA/CE-Cleared
12
Clinical Applications
Jul 2026
Last Updated

Diagnostic AI Platforms

Detailed profiles of the leading AI companies building diagnostic, screening and biomarker tools for clinical pathology.

FDA Cleared

Paige AI

New York, USA

Products: Paige Prostate, Paige Breast, FullFocus

Clinical Focus: Prostate cancer detection, breast cancer screening

Regulatory: FDA 510(k) cleared (first AI in pathology, 2021); CE-IVD marked

Technology: Deep learning on whole slide images; trained on Memorial Sloan Kettering data

Partnerships: Memorial Sloan Kettering Cancer Center, Microsoft

Integration: Compatible with major LIS platforms and scanners

Biopharma & Trials

PathAI

Boston, USA

Products: AISight, PathExplore

Clinical Focus: Biomarker quantification, clinical trial pathology, companion diagnostics

Regulatory: Clinical trials focus; regulatory submissions in progress

Technology: Multi-modal AI for tissue analysis and biomarker scoring

Partnerships: Bristol-Myers Squibb, Roche, Novartis

Integration: Cloud-based platform; scanner-agnostic

CE-IVD

Ibex Medical Analytics

Tel Aviv, Israel

Products: Galen Platform (Galen Prostate, Galen Breast, Galen Gastric)

Clinical Focus: Prostate, breast, and gastric cancer detection

Regulatory: CE-IVD marked; clinical deployment across European laboratories

Technology: CNN-based analysis; claims 99%+ sensitivity for cancer detection

Partnerships: Multiple European hospital networks

Integration: Integrates with Philips, Hamamatsu, Leica scanners and major LIS

Companion Dx

Lunit

Seoul, South Korea

Products: Lunit SCOPE (PD-L1, HER2, Immune Phenotyping)

Clinical Focus: PD-L1 scoring, HER2 quantification, immune cell phenotyping

Regulatory: CE-IVD marked

Technology: Deep learning for IHC biomarker scoring; strong in companion diagnostics

Partnerships: Guardant Health, multiple oncology networks

Integration: Cloud and on-premise deployment options

Cloud Platform

Aiforia Technologies

Helsinki, Finland

Products: Aiforia Create, Aiforia Clinical

Clinical Focus: Custom AI model training, tissue quantification, research analytics

Regulatory: CE-IVD (Aiforia Clinical); research use (Aiforia Create)

Technology: Cloud-based deep learning platform; no-code model training interface

Adoption: Used by 100+ pharmaceutical and academic organisations worldwide

Integration: Scanner-agnostic; supports all major WSI formats

Enterprise

Proscia

Philadelphia, USA

Products: Concentriq AP-Dx

Clinical Focus: Digital pathology workflow management with integrated AI applications

Regulatory: FDA and CE pathway for enterprise deployment

Technology: Enterprise-grade platform combining image management, workflow orchestration, and AI

Deployment: Cloud and hybrid deployment for health systems

Integration: Open architecture; supports third-party AI algorithm integration

Hardware + AI

Hamamatsu Photonics

Hamamatsu, Japan

Products: NanoZoomer series (S360, S60, XR) + AI analysis modules

Clinical Focus: Whole slide scanning hardware with integrated AI software modules

Regulatory: CE-IVD (scanners); FDA 510(k) cleared scanners

Technology: High-speed line-scanning optics combined with proprietary AI analysis

Market Position: Largest scanner install base globally

Integration: NDP.serve image management; open API for third-party AI

Enterprise PACS

Sectra

Linköping, Sweden

Products: Sectra Digital Pathology (part of Sectra Medical PACS)

Clinical Focus: Enterprise workflow, reporting, AI integration layer for pathology

Regulatory: CE marked; deployed across UK NHS and Scandinavian health systems

Technology: PACS-integrated digital pathology with vendor-neutral AI marketplace

Deployment: Strong in Scandinavia, UK NHS, and European health networks

Integration: Scanner-agnostic; integrates with radiology PACS, LIS, and EHR systems

Whole Slide Scanners

Comparative overview of major whole slide imaging platforms used in clinical and research pathology.

Scanner Manufacturer Speed (slides/hr) Resolution Scanning Modes Price Tier AI Integration
Aperio AT2 Leica Biosystems Up to 80 0.25 μm/pixel (40×) Brightfield Premium Leica AI ecosystem + open API
Aperio GT 450 Leica Biosystems Up to 120 0.25 μm/pixel (40×) Brightfield, continuous loading Premium Full AI integration via Aperio eSlide Manager
NanoZoomer S360 Hamamatsu Up to 120 0.23 μm/pixel (40×) Brightfield, fluorescence Premium NDP.serve + third-party AI
NanoZoomer S60 Hamamatsu Up to 40 0.23 μm/pixel (40×) Brightfield, fluorescence Mid-range NDP.serve + third-party AI
IntelliSite Ultra Fast Scanner Philips Up to 140 0.25 μm/pixel (40×) Brightfield Premium Philips AI ecosystem (FDA cleared for primary Dx)
Pannoramic SCAN II 3DHISTECH Up to 100 0.12 μm/pixel (up to 100×) Brightfield, fluorescence, FISH Mid-range CaseViewer + third-party integration
DP 200 Roche / Ventana Up to 80 0.25 μm/pixel (40×) Brightfield Premium uPath enterprise software + Roche AI
Ocus Grundium Up to 6 0.25 μm/pixel (40×) Brightfield Portable / Budget Cloud AI via open API; designed for point-of-care

Specifications are indicative and reflect manufacturer-published data as of July 2026. Contact manufacturers for current product specifications and clinical validation status.

Annotation & Training Platforms

Tools for annotating whole slide images, building training datasets and developing custom AI models for pathology research.

Open Source

QuPath

Open-source platform for whole slide image analysis. Extensive annotation tools, scripting via Groovy, built-in machine learning classifiers, and active community support. Widely adopted in academic research.

Open Source

ASAP

Automated Slide Analysis Platform. Lightweight, fast open-source viewer and annotation tool developed by the Computational Pathology Group at Radboud University Medical Center. Supports large WSI files efficiently.

Commercial

Labelbox

Enterprise data labelling platform with support for medical imaging and pathology workflows. Features include collaborative annotation, quality assurance, model-assisted labelling, and dataset management.

Commercial

V7 Labs

AI-powered annotation platform with auto-annotation capabilities for pathology images. Supports polygon, brush and semantic segmentation tools with model-in-the-loop training workflows.

Clinical & Research

SlideScore

Web-based slide scoring and annotation platform designed for pathology research studies and clinical trials. Supports multi-observer studies, scoring protocols and structured data export.

Regulatory Landscape

Regulatory clearances and approvals for AI-based pathology tools across major jurisdictions.

FDA 510(k) Cleared Pathology AI Tools

Product Company Clearance Date Intended Use Predicate Device
Paige Prostate Paige AI September 2021 Detection of areas suspicious for prostate cancer in H&E whole slide images First-of-kind (De Novo)
Philips IntelliSite Pathology Solution Philips April 2017 Primary diagnostic review of surgical pathology slides First-of-kind (De Novo)
Aperio AT2 DX System Leica Biosystems March 2019 Viewing and review of digital surgical pathology slides Philips IntelliSite
Sectra Digital Pathology Module Sectra 2022 Display and management of digital pathology images Philips IntelliSite

CE-IVD Marked Tools (Europe)

Product Company Application Status
Galen Platform Ibex Medical Analytics Cancer detection (prostate, breast, gastric) CE-IVD; deployed in clinical labs
Lunit SCOPE Lunit PD-L1, HER2, immune phenotyping CE-IVD
Paige Prostate / Breast Paige AI Cancer detection CE-IVD
Aiforia Clinical Aiforia Technologies Custom clinical AI models CE-IVD
NanoZoomer series Hamamatsu Whole slide scanning CE-IVD

SFDA Approved Tools (Saudi Arabia)

Product Company Application SFDA Status
Philips IntelliSite Philips Digital pathology primary diagnosis SFDA Registered
Aperio GT 450 Leica Biosystems Whole slide scanning SFDA Registered
Sectra Digital Pathology Sectra Pathology image management SFDA Registered

Regulatory data reflects publicly available information as of July 2026. Check with manufacturers and regulatory authorities for the most current clearance and approval status.

Master Platform Comparison

Side-by-side comparison of all reviewed AI pathology platforms across key decision criteria.

Platform Regulatory Cancer Types Deployment Pricing Model Scanner Compatibility LIS Integration Use Case
Paige AI FDA, CE-IVD Prostate, Breast Cloud + On-prem Per-case / Subscription Multi-scanner Yes (HL7, API) Clinical
PathAI Pending Multi-cancer, Biomarkers Cloud Enterprise / Per-study Scanner-agnostic API-based Research + Trials
Ibex Medical CE-IVD Prostate, Breast, Gastric On-prem + Cloud Per-case Philips, Hamamatsu, Leica Yes Clinical
Lunit CE-IVD IHC Biomarkers (PD-L1, HER2) Cloud + On-prem Per-case / Licence Multi-scanner Yes Clinical + Dx
Aiforia CE-IVD (Clinical) Customisable Cloud Subscription Scanner-agnostic API-based Research + Clinical
Proscia FDA/CE pathway Platform-dependent Cloud + Hybrid Enterprise licence Vendor-neutral Yes (HL7, DICOM) Enterprise workflow
Hamamatsu FDA, CE-IVD Scanner + AI modules On-prem Capital purchase Proprietary + open API NDP.serve integration Clinical + Research
Sectra FDA, CE AI marketplace On-prem + Hybrid Enterprise licence Vendor-neutral Full PACS/LIS/EHR Enterprise clinical

Platform capabilities and pricing models are subject to change. This comparison is intended as a general guide for initial evaluation.

How to Choose an AI Pathology Platform

A structured approach to evaluating and selecting AI tools for your laboratory or institution.

Step 1

Clinical Needs Assessment

Define the specific diagnostic challenges you are solving. Identify target cancers, biomarkers, and case volumes. Determine whether the primary use case is screening, quality assurance, quantification, or primary diagnosis.

Step 2

IT Infrastructure Requirements

Assess your existing digital pathology infrastructure. Evaluate network bandwidth, storage capacity, scanner compatibility, and whether cloud, on-premise, or hybrid deployment best fits your organisation.

Step 3

Regulatory Requirements by Country

Confirm that the platform holds the appropriate regulatory clearance for your jurisdiction. FDA 510(k) for the United States, CE-IVD under IVDR for the European Union, SFDA for Saudi Arabia, and equivalent approvals for other markets.

Step 4

Total Cost of Ownership

Calculate the full cost including licensing fees, infrastructure upgrades, scanner acquisition, storage, training, validation studies, and ongoing maintenance. Compare per-case pricing against enterprise subscription models.

Step 5

Training & Validation Requirements

Plan for pathologist training, competency assessment, and clinical validation. Establish a validation protocol aligned with CAP, RCPath or local guidelines. Consider the learning curve and change management needs.

Related Resources